Jury Gladkich

2.1k total citations
32 papers, 1.6k citations indexed

About

Jury Gladkich is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Jury Gladkich has authored 32 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 16 papers in Cancer Research and 14 papers in Oncology. Recurrent topics in Jury Gladkich's work include MicroRNA in disease regulation (12 papers), Cancer Cells and Metastasis (9 papers) and Genomics, phytochemicals, and oxidative stress (8 papers). Jury Gladkich is often cited by papers focused on MicroRNA in disease regulation (12 papers), Cancer Cells and Metastasis (9 papers) and Genomics, phytochemicals, and oxidative stress (8 papers). Jury Gladkich collaborates with scholars based in Germany, China and Austria. Jury Gladkich's co-authors include Ingrid Herr, Alexei V. Salnikov, Jürgen Mattern, Vanessa Rausch, Sabrina Labsch, Gerhard Moldenhauer, Nathalie Bauer, Peter Schemmer, Wolfgang Groß and Georgios Kallifatidis and has published in prestigious journals such as PLoS ONE, Cancer Research and Clinical Cancer Research.

In The Last Decade

Jury Gladkich

32 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jury Gladkich Germany 22 1.0k 724 643 137 134 32 1.6k
Georgios Kallifatidis United States 18 940 0.9× 646 0.9× 364 0.6× 214 1.6× 124 0.9× 26 1.7k
Ina A. Eilertsen Norway 16 943 0.9× 784 1.1× 498 0.8× 146 1.1× 186 1.4× 26 1.7k
Alexei V. Salnikov Germany 17 870 0.8× 802 1.1× 433 0.7× 183 1.3× 153 1.1× 23 1.6k
Leina Ma China 24 1.6k 1.6× 536 0.7× 793 1.2× 186 1.4× 164 1.2× 50 2.2k
Chi-Hung Huang Taiwan 15 1.2k 1.2× 713 1.0× 497 0.8× 110 0.8× 127 0.9× 27 1.8k
Mina Maftouh Iran 26 1.2k 1.2× 648 0.9× 752 1.2× 197 1.4× 189 1.4× 39 1.9k
Amro Aboukameel United States 31 2.0k 1.9× 1.0k 1.4× 611 1.0× 219 1.6× 166 1.2× 91 2.8k
Sheng-Chieh Hsu Taiwan 16 1.0k 1.0× 811 1.1× 364 0.6× 151 1.1× 286 2.1× 16 1.7k
Alexandra Grassian United States 12 1.2k 1.2× 367 0.5× 797 1.2× 106 0.8× 125 0.9× 17 1.7k
Rosa Puca Italy 20 837 0.8× 552 0.8× 392 0.6× 110 0.8× 63 0.5× 31 1.3k

Countries citing papers authored by Jury Gladkich

Since Specialization
Citations

This map shows the geographic impact of Jury Gladkich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jury Gladkich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jury Gladkich more than expected).

Fields of papers citing papers by Jury Gladkich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jury Gladkich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jury Gladkich. The network helps show where Jury Gladkich may publish in the future.

Co-authorship network of co-authors of Jury Gladkich

This figure shows the co-authorship network connecting the top 25 collaborators of Jury Gladkich. A scholar is included among the top collaborators of Jury Gladkich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jury Gladkich. Jury Gladkich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Li, Shanshan Han, Xi Xiao, et al.. (2022). Glucocorticoid-induced microRNA-378 signaling mediates the progression of pancreatic cancer by enhancing autophagy. Cell Death and Disease. 13(12). 1052–1052. 21 indexed citations
2.
Yan, Bin, Li Liu, Ulf Hinz, et al.. (2022). Tumor and stroma COL8A1 secretion induces autocrine and paracrine progression signaling in pancreatic ductal adenocarcinoma. Matrix Biology. 114. 84–107. 16 indexed citations
3.
Liu, Li, Bin Yan, Carolina De La Torre, et al.. (2022). Nanosilver inhibits the progression of pancreatic cancer by inducing a paraptosis-like mixed type of cell death. Biomedicine & Pharmacotherapy. 153. 113511–113511. 8 indexed citations
4.
Han, Shanshan, et al.. (2022). UHMK1 Is a Novel Marker for Personalized Prediction of Pancreatic Cancer Prognosis. Frontiers in Oncology. 12. 834647–834647. 6 indexed citations
5.
Ji, Huihui, et al.. (2021). Sulforaphane Targets TRA-1/GLI Upstream of DAF-16/FOXO to Promote C. elegans Longevity and Healthspan. Frontiers in Cell and Developmental Biology. 9. 784999–784999. 8 indexed citations
6.
Yan, Bin, Li Liu, Libo Yin, et al.. (2021). Sulforaphane Inhibits the Expression of Long Noncoding RNA H19 and Its Target APOBEC3G and Thereby Pancreatic Cancer Progression. Cancers. 13(4). 827–827. 20 indexed citations
7.
Bai, Liping, et al.. (2021). Therapy of pancreatic cancer with alternating electric fields: Limitations of the method. Bioelectrochemistry. 141. 107881–107881. 6 indexed citations
8.
Yin, Libo, Xi Xiao, Li Liu, et al.. (2019). MicroRNA-365a-3p inhibits c-Rel-mediated NF-κB signaling and the progression of pancreatic cancer. Cancer Letters. 452. 203–212. 34 indexed citations
9.
Yin, Libo, Xi Xiao, Li Liu, et al.. (2019). Sulforaphane Induces miR135b-5p and Its Target Gene, RASAL2, thereby Inhibiting the Progression of Pancreatic Cancer. Molecular Therapy — Oncolytics. 14. 74–81. 39 indexed citations
10.
Abukiwan, Alia, Clifford C. Nwaeburu, Nathalie Bauer, et al.. (2018). Dexamethasone-induced inhibition of miR-132 via methylation promotes TGF-β-driven progression of pancreatic cancer. International Journal of Oncology. 54(1). 53–64. 25 indexed citations
11.
Liu, Li, Ewa Aleksandrowicz, Frank Schönsiegel, et al.. (2017). Dexamethasone mediates pancreatic cancer progression by glucocorticoid receptor, TGFβ and JNK/AP-1. Cell Death and Disease. 8(10). e3064–e3064. 46 indexed citations
12.
Fan, Pei, Li Liu, Zhefu Zhao, et al.. (2016). MicroRNA-101-3p reverses gemcitabine resistance by inhibition of ribonucleotide reductase M1 in pancreatic cancer. Cancer Letters. 373(1). 130–137. 50 indexed citations
13.
Fan, Pei, Zhong Zhao, Xi Xiao, et al.. (2016). Continuous exposure of pancreatic cancer cells to dietary bioactive agents does not induce drug resistance unlike chemotherapy. Cell Death and Disease. 7(6). e2246–e2246. 41 indexed citations
14.
Aleksandrowicz, Ewa, Pei Fan, Frank Schönsiegel, et al.. (2014). Enrichment of c-Met+ tumorigenic stromal cells of giant cell tumor of bone and targeting by cabozantinib. Cell Death and Disease. 5(10). e1471–e1471. 25 indexed citations
15.
Hage, Carina, Vanessa Rausch, Nathalia A. Giese, et al.. (2013). The novel c-Met inhibitor cabozantinib overcomes gemcitabine resistance and stem cell signaling in pancreatic cancer. Cell Death and Disease. 4(5). e627–e627. 101 indexed citations
16.
Salnikov, Alexei V., Jury Gladkich, Li Liu, et al.. (2012). New Gene-Immunotherapy Combining TRAIL-Lymphocytes and EpCAMxCD3 Bispecific Antibody for Tumor Targeting. Clinical Cancer Research. 18(4). 1028–1038. 16 indexed citations
17.
Rausch, Vanessa, Li Liu, Anja Apel, et al.. (2012). Autophagy mediates survival of pancreatic tumour‐initiating cells in a hypoxic microenvironment. The Journal of Pathology. 227(3). 325–335. 112 indexed citations
18.
Salnikov, Alexei V., Li Liu, Mitja Platen, et al.. (2012). Hypoxia Induces EMT in Low and Highly Aggressive Pancreatic Tumor Cells but Only Cells with Cancer Stem Cell Characteristics Acquire Pronounced Migratory Potential. PLoS ONE. 7(9). e46391–e46391. 113 indexed citations
19.
Rausch, Vanessa, Li Liu, Georgios Kallifatidis, et al.. (2010). Synergistic Activity of Sorafenib and Sulforaphane Abolishes Pancreatic Cancer Stem Cell Characteristics. Cancer Research. 70(12). 5004–5013. 169 indexed citations
20.
Kallifatidis, Georgios, Sabrina Labsch, Vanessa Rausch, et al.. (2010). Sulforaphane Increases Drug-mediated Cytotoxicity Toward Cancer Stem-like Cells of Pancreas and Prostate. Molecular Therapy. 19(1). 188–195. 174 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Georgios Kallifatidis Breakdown of academic impact, for papers by Ina A. Eilertsen Breakdown of academic impact, for papers by Alexei V. Salnikov Breakdown of academic impact, for papers by Leina Ma Breakdown of academic impact, for papers by Chi-Hung Huang Breakdown of academic impact, for papers by Mina Maftouh Breakdown of academic impact, for papers by Amro Aboukameel Breakdown of academic impact, for papers by Sheng-Chieh Hsu Breakdown of academic impact, for papers by Alexandra Grassian Breakdown of academic impact, for papers by Rosa Puca
Rankless by CCL
2026